Cargando…
DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study
Gastric cancer is the fourth most common type of cancer globally and accounts for the second highest cancer-associated mortality rate in the world. Current treatment strategies for gastric cancer include surgery, radiotherapy, chemotherapy and targeted therapy. Intraperitoneal (IP) chemotherapy may...
Autores principales: | FENG, ZENG-LI, CHEN, LIU-BIN, LIU, ZHEN-YU, CHEN, XUE-JI, REN, XIAO-CAN, LIU, YUE-E, PENG, YU, WANG, HAI-GANG, MA, SHUN-MAO, MENG, FENG-JIE, LIN, QIANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246631/ https://www.ncbi.nlm.nih.gov/pubmed/25436015 http://dx.doi.org/10.3892/ol.2014.2651 |
Ejemplares similares
-
Comparison of short-term efficacy and safety of TIROX and DCF
regimens for advanced gastric cancer
por: Dong, Lei, et al.
Publicado: (2014) -
Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
por: GÜRLER, Fatih, et al.
Publicado: (2022) -
The efficacy and adverse reactions of DCF and FOLFOXs regimens for patients with advanced gastric cancer in China: a meta-analysis
por: Chen, Minxue, et al.
Publicado: (2020) -
Docetaxel, Cisplatin and Fluorouracil (DCF) Regimen Compared with Non-Taxane-Containing Palliative Chemotherapy for Gastric Carcinoma: A Systematic Review and Meta-Analysis
por: Chen, Xiao-Long, et al.
Publicado: (2013) -
Comparison the Incidence and Severity of Side Effects Profile Of FOLFOX and DCF Regimens in Gastric Cancer Patients
por: Salehifar, Ebrahim, et al.
Publicado: (2019)